PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 22, 2026Biological Research0 citationsOpen Access

Ameliorative effect of pomegranate peel extract nanoparticles and ovarian stem cells-derived exosomes on cyclophosphamide-induced premature ovarian insufficiency

View Full Paper
HIHamdy Y. IsmailMFMariam F. FaridNSNora A. Shaker

Key Points

  • The central aim is to evaluate the effectiveness of pomegranate peel extract nanoparticles and ovarian stem cell-derived exosomes in treating premature ovarian insufficiency caused by cyclophosphamide.
  • Forty female albino rats were divided into four groups: a control and three treatment groups.
  • Premature ovarian insufficiency was induced in rats using cyclophosphamide injections.
  • Group III received pomegranate nanoparticles orally, while Group IV received both pomegranate nanoparticles and exosomes.
  • Hormonal levels were assessed, and ovarian histopathology and gene expression were analyzed post-treatment.
  • Group II showed decreased estrogen and increased follicle-stimulating hormone compared to control and treated groups.
  • Notable ovarian follicle degeneration occurred in Group II, while Groups III and IV exhibited improved ovarian structure and function.
  • Pomegranate extract and exosome treatments led to elevated estrogen levels and increased follicle counts in treated groups.
  • Gene expression analysis indicated up-regulation of key hormonal and follicular genes in the treatment groups.

Abstract

Abstract Background Premature ovarian insufficiency (POI) is a fertility disorder impacting women under 40, characterized by an early deterioration of ovarian function, and is one of the major side effects caused by chemotherapy. Cyclophosphamide is a powerful chemotherapeutic agent used in various cancers; however, it inflicts substantial harm on other tissues, particularly the gonads, leading to temporary or permanent infertility. Materials and methods Forty female albino rats (Rattus norvegicus) were divided into four groups. Group I (control group) received normal saline, then premature ovarian insufficiency was induced in the remaining groups by intraperitoneal injections of cyclophosphamide (CLP). After that, Group II received no treatment. Group III was administered a daily oral dose of pomegranate ( Punica granatum ) nanoparticles for one month. Group IV received a daily oral dose of pomegranates, as did group III, plus ovarian stem cell-derived exosomes via intraperitoneal injection twice weekly for one month. Rats were euthanized 30 days post-POI induction; blood was then collected to evaluate hormone levels, and sections of the ovaries were collected for histopathological analysis. Frozen sections were procured for gene expression and oxidative stress studies. Results The hormonal assessment of groups indicated a notable reduction in estrogen (E2) level and an elevation of follicle-stimulating hormone (FSH) in group II compared to the control and treated groups. Additionally, the ovaries of group II exhibited pronounced degeneration of ovarian follicles, accompanied by the desquamation of granulosa cells. Gene expression study indicated a downregulation of FSHR, CYP19A1, and AMH in the same group. Rats in both groups III and IV exhibited an increased number of follicles, improved ovarian shape, a considerable elevation in blood E2, a marked decrease in serum FSH levels, and an up-regulation of the three examined genes. Aim of work The study aimed to assess the therapeutic efficacy of pomegranate ( Punica granatum ) peel extract nanoparticles alone and their synergistic effect with ovarian stem cell exosomes in reversing premature ovarian insufficiency (POI) caused by cyclophosphamide. Conclusion Treatment with ( Punica granatum ) nanoparticles and exosomes partially enhanced the structure and function of the ovaries, thereby alleviating the adverse effects of Cyclophosphamide.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ismail et al. (2026) studied this question.

synapsesocial.com/papers/6971bd26642b1836717e1e8ehttps://doi.org/10.1186/s40659-025-00664-9
Ask AI
Helpful
Bookmark
Share
View Full Paper